Mubarak Naji Bin Mubarak Al Yami, Mahdi Ali Bin Mohammed Al Sharyah, Ahmad Saleh Al Qahhat, Mahdi Yami, Ali Saleh Bin Ali Almassad, Saeedah Hamad Hassan Alshaiban, Mohammed Dhafer Abdullah Alghubari, Amal Abdullah Yahya Al Shahrani, Muhammad Husain Al Mutlaq, Fahad Saleh Mohd Albakry, Fatima Mohammad Saad Al Shahranii
{"title":"Role of Interventional Radiology in Management of Hepato-Cellular Carcinoma (HCC)","authors":"Mubarak Naji Bin Mubarak Al Yami, Mahdi Ali Bin Mohammed Al Sharyah, Ahmad Saleh Al Qahhat, Mahdi Yami, Ali Saleh Bin Ali Almassad, Saeedah Hamad Hassan Alshaiban, Mohammed Dhafer Abdullah Alghubari, Amal Abdullah Yahya Al Shahrani, Muhammad Husain Al Mutlaq, Fahad Saleh Mohd Albakry, Fatima Mohammad Saad Al Shahranii","doi":"10.36348/sjpm.2022.v07i12.002","DOIUrl":null,"url":null,"abstract":"The most typical primary liver tumour, hepatocellular carcinoma, is becoming more prevalent. The two-gold standard curative treatment options are transplantation and surgical resection, but fewer than 20% of patients qualify as surgical candidates due to severe liver disease and/or co-morbidities. For the treatment of HCC that is inoperable, numerous interventional radiological techniques have been developed and thoroughly researched. The treatment of HCC currently heavily relies on interventional radiology. These methods have considerably aided in halting disease development in liver transplant candidates and extending survival in non-candidates. These medicines stand out for their low toxicity profiles, potent tumour response, and preservation of healthy hepatic parenchyma.","PeriodicalId":407259,"journal":{"name":"Saudi Journal of Pathology and Microbiology","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Journal of Pathology and Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/sjpm.2022.v07i12.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The most typical primary liver tumour, hepatocellular carcinoma, is becoming more prevalent. The two-gold standard curative treatment options are transplantation and surgical resection, but fewer than 20% of patients qualify as surgical candidates due to severe liver disease and/or co-morbidities. For the treatment of HCC that is inoperable, numerous interventional radiological techniques have been developed and thoroughly researched. The treatment of HCC currently heavily relies on interventional radiology. These methods have considerably aided in halting disease development in liver transplant candidates and extending survival in non-candidates. These medicines stand out for their low toxicity profiles, potent tumour response, and preservation of healthy hepatic parenchyma.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
